145 related articles for article (PubMed ID: 29758193)
21. Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer.
Koliopanos A; Kleeff J; Xiao Y; Safe S; Zimmermann A; Büchler MW; Friess H
Oncogene; 2002 Sep; 21(39):6059-70. PubMed ID: 12203118
[TBL] [Abstract][Full Text] [Related]
22. Omeprazole Attenuates Pulmonary Aryl Hydrocarbon Receptor Activation and Potentiates Hyperoxia-Induced Developmental Lung Injury in Newborn Mice.
Shivanna B; Zhang S; Patel A; Jiang W; Wang L; Welty SE; Moorthy B
Toxicol Sci; 2015 Nov; 148(1):276-87. PubMed ID: 26272953
[TBL] [Abstract][Full Text] [Related]
23. Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial-mesenchymal transition in non-small cell lung cancer cells.
Li CH; Liu CW; Tsai CH; Peng YJ; Yang YH; Liao PL; Lee CC; Cheng YW; Kang JJ
Arch Toxicol; 2017 May; 91(5):2165-2178. PubMed ID: 27752740
[TBL] [Abstract][Full Text] [Related]
24. A tetratricopeptide repeat half-site in the aryl hydrocarbon receptor is important for DNA binding and trans-activation potential.
Levine SL; Petrulis JR; Dubil A; Perdew GH
Mol Pharmacol; 2000 Dec; 58(6):1517-24. PubMed ID: 11093792
[TBL] [Abstract][Full Text] [Related]
25. Omeprazole Inhibits Glioblastoma Cell Invasion and Tumor Growth.
Jin UH; Michelhaugh SK; Polin LA; Shrestha R; Mittal S; Safe S
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32731514
[No Abstract] [Full Text] [Related]
26. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling.
Kwon GT; Cho HJ; Chung WY; Park KK; Moon A; Park JH
J Nutr Biochem; 2009 Sep; 20(9):663-76. PubMed ID: 18824345
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of aryl hydrocarbon receptor expression decreases gastric cancer cell growth and invasion.
Yin XF; Chen J; Mao W; Wang YH; Chen MH
Oncol Rep; 2013 Jul; 30(1):364-70. PubMed ID: 23604401
[TBL] [Abstract][Full Text] [Related]
28. Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathway.
Li W; Chen Z; Gong FR; Zong Y; Chen K; Li DM; Yin H; Duan WM; Miao Y; Tao M; Han X; Xu ZK
Eur J Cancer; 2011 Nov; 47(17):2654-64. PubMed ID: 21958460
[TBL] [Abstract][Full Text] [Related]
29. Nuclear uptake of the Ah (dioxin) receptor in response to omeprazole: transcriptional activation of the human CYP1A1 gene.
Quattrochi LC; Tukey RH
Mol Pharmacol; 1993 Apr; 43(4):504-8. PubMed ID: 8386305
[TBL] [Abstract][Full Text] [Related]
30. Broad transcriptional response of the human esophageal epithelium to proton pump inhibitors.
Rochman M; Xie YM; Mack L; Caldwell JM; Klingler AM; Osswald GA; Azouz NP; Rothenberg ME
J Allergy Clin Immunol; 2021 May; 147(5):1924-1935. PubMed ID: 33289661
[TBL] [Abstract][Full Text] [Related]
31. Differential ligand-dependent activation and a role for Y322 in aryl hydrocarbon receptor-mediated regulation of gene expression.
Powis M; Celius T; Matthews J
Biochem Biophys Res Commun; 2011 Jul; 410(4):859-65. PubMed ID: 21703235
[TBL] [Abstract][Full Text] [Related]
32. Microtubules-interfering agents restrict aryl hydrocarbon receptor-mediated CYP1A2 induction in primary cultures of human hepatocytes via c-jun-N-terminal kinase and glucocorticoid receptor.
Vrzal R; Daujat-Chavanieu M; Pascussi JM; Ulrichova J; Maurel P; Dvorak Z
Eur J Pharmacol; 2008 Mar; 581(3):244-54. PubMed ID: 18177856
[TBL] [Abstract][Full Text] [Related]
33. Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation.
Backlund M; Ingelman-Sundberg M
Mol Pharmacol; 2004 Feb; 65(2):416-25. PubMed ID: 14742684
[TBL] [Abstract][Full Text] [Related]
34. Activation of the aryl hydrocarbon receptor by the calcium/calmodulin-dependent protein kinase kinase inhibitor 7-oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic acid (STO-609).
Monteiro P; Gilot D; Langouet S; Fardel O
Drug Metab Dispos; 2008 Dec; 36(12):2556-63. PubMed ID: 18755850
[TBL] [Abstract][Full Text] [Related]
35. Dimethylenastron suppresses human pancreatic cancer cell migration and invasion in vitro via allosteric inhibition of mitotic kinesin Eg5.
Sun XD; Shi XJ; Sun XO; Luo YG; Wu XJ; Yao CF; Yu HY; Li DW; Liu M; Zhou J
Acta Pharmacol Sin; 2011 Dec; 32(12):1543-8. PubMed ID: 21986572
[TBL] [Abstract][Full Text] [Related]
36. Aryl hydrocarbon (Ah) receptor levels are selectively modulated by hsp90-associated immunophilin homolog XAP2.
Meyer BK; Petrulis JR; Perdew GH
Cell Stress Chaperones; 2000 Jul; 5(3):243-54. PubMed ID: 11005382
[TBL] [Abstract][Full Text] [Related]
37. Omeprazole attenuates hyperoxic injury in H441 cells via the aryl hydrocarbon receptor.
Shivanna B; Chu C; Welty SE; Jiang W; Wang L; Couroucli XI; Moorthy B
Free Radic Biol Med; 2011 Nov; 51(10):1910-7. PubMed ID: 21906671
[TBL] [Abstract][Full Text] [Related]
38. The Jun N-terminal kinase inhibitor SP600125 is a ligand and antagonist of the aryl hydrocarbon receptor.
Joiakim A; Mathieu PA; Palermo C; Gasiewicz TA; Reiners JJ
Drug Metab Dispos; 2003 Nov; 31(11):1279-82. PubMed ID: 14570754
[TBL] [Abstract][Full Text] [Related]
39. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling.
Yeh CT; Wu CH; Yen GC
Mol Nutr Food Res; 2010 Sep; 54(9):1285-95. PubMed ID: 20352621
[TBL] [Abstract][Full Text] [Related]
40. Tryptophan photo-product FICZ upregulates AHR/MEK/ERK-mediated MMP1 expression: Implications in anti-fibrotic phototherapy.
Murai M; Yamamura K; Hashimoto-Hachiya A; Tsuji G; Furue M; Mitoma C
J Dermatol Sci; 2018 Jul; 91(1):97-103. PubMed ID: 29703420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
